Skip to main content
https://pbs.twimg.com/media/HJ5eQDgWsAAXe81.png
🤔 Best endpoint for #PsA trials? #POS0046: GRAPPA-OMERACT NMA (24 trials, n=12,000): MDA wins! (OR 5.06) 📊 #EULAR2026 @RheumNow https://t.co/3KWaKcvF0a
Nelly ZIADE 🍀
Jun-03-2026
×